Sanjivani Paranteral informs about un-audited financial results

14 Feb 2022 Evaluate

In compliance with Regulation 33 of SEBI (Listing Obligations & Disclosure Requirements) Regulation 2015, Sanjivani Paranteral has informed that it enclosed the copy of Un-Audited Financial Results of the Company for the quarter ended 31st December 2021 together with a copy of the Limited Review Report as received from the Statutory Auditors of the Company. The aforesaid Un-Audited Financial Results were approved / taken on record by the Board of Directors at their meeting held on 14th February 2022. The Board meeting commenced at 01.45 pm and concluded at 02.30 pm.

The above information is a part of company’s filings submitted to BSE.

Sanjivani Paranteral Share Price

205.45 -11.95 (-5.50%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×